Date published: 2026-3-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

GnT-V Inhibitors

GnT-V inhibitors as a chemical class represent a group of compounds that, either directly or indirectly, interfere with the enzymatic function of N-acetylglucosaminyltransferase V. This enzyme is crucial for the addition of N-acetylglucosamine in a beta-1,6 linkage to the core mannose of N-glycan, a modification that can affect protein folding, stability, and cell signaling. The chemical inhibitors identified often target the broader glycosylation process, of which GnT-V is a part. The primary mode of action is through the inhibition of mannosidases or glucosidases, which are enzymes that process the N-glycans before GnT-V acts upon them. By inhibiting these enzymes, the pool of substrates that GnT-V would normally act upon is altered, thereby reducing the enzyme's activity indirectly. These inhibitors tend to be competitive, meaning they bind to the active site of the glycosidases they target, preventing the natural substrate from binding and thus inhibiting the process. The alteration in glycan structure due to the presence of these inhibitors can lead to changes in the function of the proteins to which they are attached, affecting cellular signaling and protein-protein interactions that rely on these glycosylated molecules. These chemical inhibitors have significant biochemical relevance. Since GnT-V is responsible for a specific and important glycosylation step, any modification in its activity can have wide-ranging effects on cellular processes. By modulating the enzyme's activity through indirect inhibition, it is possible to alter the glycan structures on glycoproteins, which can have downstream effects on cellular communication, protein stability, and cell surface recognition. This underscores the complex interplay between various biochemical pathways and how the modulation of one specific enzyme's activity can lead to significant changes in cell biology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

An indolizidine alkaloid that inhibits mannosidase II, an enzyme upstream of GnT-V in the glycosylation pathway, thereby indirectly reducing GnT-V substrate availability.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$135.00
$540.00
$1025.00
$6248.00
25
(2)

A natural product that acts as a mannosidase I inhibitor, leading to misfolded glycoproteins and potentially decreasing GnT-V mediated glycan branching due to substrate alteration.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

An indolizidine alkaloid similar to swainsonine, which inhibits glucosidases involved in N-glycan trimming, potentially impacting the substrates available for GnT-V action.

Deoxymannojirimycin hydrochloride

84444-90-6sc-201360
sc-201360A
1 mg
5 mg
$93.00
$239.00
2
(0)

A mannosidase inhibitor that could lead to improper glycoprotein processing, indirectly affecting GnT-V by altering the glycan structures it acts upon.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

Analogous to DMJ, DNJ inhibits mannosidase, potentially influencing the glycoprotein substrates and their processing by GnT-V.